full-year call. good fourth quarter And XXXX to our Joe. morning welcome Thanks, earnings and and
families the this get related to your In light I unprecedented hope safe taking as thank ways we to coronavirus the you to and through this find all the you healthy, morning join and for I are remain all significant us. time pandemic, of event. disruptions
our record our $XX in to and I'm that our team XX% performance. in full our revenue EBITDA with our XX% of the model progress revenue year. of and grew plan increased and of quarter XXXX pleased QX the strength respectively. on achieved platform in generated revenue extremely delivered for million, strategic executed both XX% drove financial XX% and Turning Adjusted we growth fourth The as profitability. XXXX, full year, the and successfully and
in increase efficiencies delivering disciplined by Our adjusted cash operational for EBITDA throughout managing full results fourth XXXX, XX% and year the an is XX% the year. and solid and approach to Company of margins flow with growth improved quarter and operations provided XX% the net of of
margins. making continue our We progress adjusted XX% achieving goal of substantial towards EBITDA
modified platforms: Services, our of and Services, Medical reporting Therapy segment Equipment DME. visibility the Durable We Integrated two into operations to have business our improve ITS;
provider. features (sic) of insurance ITS therapies payor services management paid ITS be seek Our our patient's platform The segment wound where pressure medical we by high-margin model are in our to third-party comprised turnkey utilizes and therapy. the and is pain compromised negative oncology,
logistic providing provide biomedical support, to most we equipment, and addition handle In clinical issues. services
we focusing our providers is platform return healthcare take Our strong where on biomedical direct pump and a relative margin business payor lower is margins and comprised DME by DME of paid to the model concierge seek DME where services. sales consumable Services rentals, be a and high-turn approach, assets. directly. higher opportunities, utilizes direct we delivering on
margin a of of DME revenues with XXXX, XX.X%. year gross accounted of with ITS segment for the revenues and a XX% full segment accounted net net XX.X% margin XX% the For for of gross
well the during evidenced leading in oncology. as the growth great as capturing direct The from market our progress by the our largest in of contribute share gains. provider, to exits made share our market year-over-year year, Our XX% market as oncology elastomeric competitor pump team
year, contracts payors, X,XXX business now more XX% we clinics and relationships than payor with America. have For nearly our in XXX to North increased the outpatient oncology
solid for year. traction growth the Pain management continues gain to with
team The estimated list. is in block we therapy prior peripheral Revenue similar continues care a have large and versus nerve hospitals doubled acute growing approximately possible pain to $XXX to Our is post-surgical XXXX. XXXX market in customer million year, for believe annually. for management growth the
a have game-changer a to the which believe will significant begun with addition ITS the moving year We platform, we forward. be
$XXX device with combination an ITS annual This Cardinal's will this as partnered have wound pressure potential demonstrates home partnership, and enter our Health estimated platform in unique platform. market negative addressable of capabilities our be ITS million. be Cardinal has therapy, we significant partnered new We believe with which I powerful care to market. in health a
significant into coming for expect a within negative pressure contribution stage growth in was expand therapies is years We platforms. as a from the future setting both
Officer to provide results. financial And to of new review our with would Steele, that, I a Financial welcome like Chief our Barry